HCA Healthcare, Inc.

HCA Healthcare Medical Care Facilities

HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.

457.58 10.92 −2.33%
Market cap
$101.4B
P/E
15.3×
Fwd P/E
12.3×
Dividend yield
0.67%
F-score
7/9
Altman Z
2.80
Beneish M
−2.87
Dividend safety
78/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
13.05 16.27 16.45 16.47

+8 more quarters

P/S ratio
1.10 1.39 1.46 1.33
P/FCF ratio
14.34 13.35 14.35 12.26
P/Operating CF
36.82 52.54 46.79 22.48
P/B ratio
0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
1.73 2.00 2.06 1.92
EV/EBITDA
8.50 9.75 9.98 9.39
EV/Operating CF
12.11 11.76 12.33 11.12
EV/FCF
22.46 19.29 20.26 17.63
Quick Ratio
0.77 0.64 0.73 0.64
Current Ratio
0.99 0.83 0.97 0.85
Net Debt/EBITDA
12.06 12.35 11.02 11.22
Debt/Assets
78.61% 78.15% 76.57% 74.50%
Debt/Equity
(15.49) (16.13) (16.78) (20.62)
Asset Turnover
1.27 1.26 1.26 1.25
Operating CF/Net income
1.37 1.24 1.26 2.69
Capex/Depreciation
(1.29) (1.19) (1.61) (1.44)
Interest Coverage
5.15 4.92 5.60 5.31
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
40.98% 43.35% 42.84% 43.65%
Intangible Assets out of Total Assets
0.17 0.17 0.17 0.17
Share Based Compensation of Revenue
0.42% 0.45% 0.51% 0.54%
Graham Net Nets
(0.57) (0.46) (0.43) (0.47)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
7.66% 6.14% 6.08% 6.07%
Free Cash Flow Yield
6.97% 7.49% 6.97% 8.16%
Revenue per Share
91.73 85.47 82.54 82.27
Operating CF per Share
10.59 9.01 9.98 18.96
Capex per Share
(5.58) (5.00) (6.30) (5.53)
Free Cash Flow per Share
5.01 4.00 3.68 13.43
Cash per Share
4.59 4.20 4.40 4.28
Shareholders Equity per Share
(14.55) (13.32) (11.72) (9.27)
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(14.55) (13.32) (11.72) (9.27)
Free Cash Flow
1,104.00 895.00 870.00 3,128.00
Working Capital
(122.00) (3,206.00) (567.00) (2,611.00)
Capital Expenditures
(1,231.00) (1,119.00) (1,489.00) (1,288.00)
Net Current Asset Value
(49,269.00) (48,376.00) (47,708.00) (46,621.00)
EV/EBIT
11.10 12.70 12.94 12.21
Capex to Sales
0.06 0.06 0.08 0.07
Price to Operating Income
7.08 8.79 9.16 8.49
Other line items
Average Receivables
11,370.00 11,206.00 10,809.00 10,171.50
Average Payables
4,501.00 4,647.00 4,467.50 4,393.50
Average Inventory
1,727.00 1,737.50 1,695.00 1,755.00
Average Assets
61,393.00 60,624.00 60,116.50 59,603.00
Average Common Equity
(2,223.50) (1,708.00) (1,108.00) (686.50)

Fold the line items

Columns are period end dates